Signacor
signacor.co.uk
Actively hiring
Biotechnology
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Team
1-10
employees, estimated range
Backers
2
Zinc, Clarendon Fund Managers
Momentum
0/100
no fresh signals
Tractionpublic signals, read monthly
Web presence
top 12%
of 133.2M domains by links, Common Crawl
Backed byfrom the funds' portfolios and accelerator catalogs
Zinc 
Clarendon Fund Managers Similar startupsby what they do, their industry and backers
Vetbiolix is a veterinary biotech developing first-in-class therapeutics for pets. Targeting Osteoarthritis, Periodontitis & Gut Motility…
Curevo Vaccine is a clinical-stage biotech company dedicated to developing next-generation adjuvanted subunit vaccines to the market…
ABOUT US CONNECTA Therapeutics S.L. is a clinical-stage biotech company pioneering first-in-class neuroplasticity modulators to address…
Alpheus is advancing a new therapeutic approach designed to improve outcomes while reducing treatment burden for patients and families.
Scioto Biosciences is a preclinical stage biotech company dedicated to innovative research and discovery in the field of microbiome…
Isoform Oncology is a new biotech exploiting isoform switching and alternative splicing for the development of new biotherapeutics.
Overview
SignaCor, a UK based, clinical stage biotech company are pioneering a first-in-class therapeutic approach to symptomatic hypertrophic cardiomyopathy (HCM).